Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure

[1]  I. Lasithiotaki,et al.  Role of Smoking in the Evolution of Cardiovascular Magnetic Resonance and Laboratory Findings of Acute Myocarditis , 2020, Heart views : the official journal of the Gulf Heart Association.

[2]  T. Ganz Anemia of Inflammation. , 2019, The New England journal of medicine.

[3]  Chihiro Koike,et al.  Squamous cell carcinoma of the common bile duct: A case report with genomic profiling , 2019, Pathology international.

[4]  L. Zakhama,et al.  Diagnostic characteristics of acute myocarditis. , 2019, La Tunisie medicale.

[5]  Yang Liu,et al.  Application value of hypersensitive C-reactive protein, lactic acid and myoglobin in the combined detection of myocarditis , 2019, Experimental and therapeutic medicine.

[6]  Yi Zhou,et al.  Association between polymorphisms in estrogen metabolism genes and breast cancer development in Chinese women , 2018, Medicine.

[7]  K. Kreitner,et al.  Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all‐comer population of patients with heart failure: a retrospective analysis , 2018, ESC heart failure.

[8]  Michael S Marber,et al.  Cardiac troponins: from myocardial infarction to chronic disease , 2017, Cardiovascular research.

[9]  H. Ullum,et al.  Prevalence of restless legs syndrome and associated factors in an otherwise healthy population: results from the Danish Blood Donor Study. , 2017, Sleep medicine.

[10]  K. Clarke,et al.  An essential cell-autonomous role for hepcidin in cardiac iron homeostasis , 2016, eLife.

[11]  Matthias Gutberlet,et al.  Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.

[12]  H. Ullum,et al.  Low‐grade inflammation is associated with lower haemoglobin levels in healthy individuals: results from the Danish blood donor study , 2016, Vox sanguinis.

[13]  Vijay Nambi,et al.  Troponin in Cardiovascular Disease Prevention: Updates and Future Direction , 2016, Current Atherosclerosis Reports.

[14]  N. Andrews,et al.  Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart. , 2015, Cell reports.

[15]  T. Münzel,et al.  Feasibility and safety of left ventricular endomyocardial biopsy via transradial access: Technique and initial experience , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[16]  C. Tschöpe,et al.  Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome , 2014, European journal of heart failure.

[17]  T. Ganz,et al.  Anemia of inflammation. , 2014, Hematology/oncology clinics of North America.

[18]  A. Struthers,et al.  High BNP levels in rheumatoid arthritis are related to inflammation but not to left ventricular abnormalities: a prospective case-control study. , 2014, International journal of cardiology.

[19]  C. Forleo,et al.  Independent Role of Left Ventricular Global Longitudinal Strain in Predicting Prognosis of Chronic Heart Failure Patients , 2013, Echocardiography.

[20]  C. Tschöpe,et al.  New Echocardiographic Findings Correlate with Intramyocardial Inflammation in Endomyocardial Biopsies of Patients with Acute Myocarditis and Inflammatory Cardiomyopathy , 2013, Mediators of inflammation.

[21]  J. Kautzner,et al.  Utility of combination of cardiac magnetic resonance imaging and high-sensitivity cardiac troponin T assay in diagnosis of inflammatory cardiomyopathy. , 2013, The American journal of cardiology.

[22]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[23]  A. Casaleggio,et al.  Ventricular Tachyarrhythmias in Implantable Cardioverter Defibrillator Recipients: Differences Between Ischemic and Dilated Cardiomyopathies , 2011 .

[24]  Thomas H. Marwick,et al.  Prediction of All-Cause Mortality From Global Longitudinal Speckle Strain: Comparison With Ejection Fraction and Wall Motion Scoring , 2009, Circulation. Cardiovascular imaging.

[25]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[26]  C. Schneider,et al.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. , 2008, European heart journal.

[27]  K. Bailey,et al.  Usefulness of immunosuppression for giant cell myocarditis. , 2008, The American journal of cardiology.

[28]  Jeroen J. Bax,et al.  Relation between global left ventricular longitudinal strain assessed with novel automated function imaging and biplane left ventricular ejection fraction in patients with coronary artery disease. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[29]  WolfgangHoffmann,et al.  Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach , 2008 .

[30]  W. Hoffmann,et al.  Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period , 2008, Circulation.

[31]  D. Pennell,et al.  The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. , 2008, European heart journal.

[32]  A. D. de Bold,et al.  Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis. , 2008, American journal of physiology. Heart and circulatory physiology.

[33]  L. Landini,et al.  Smoking and cardiovascular system: cellular features of the damage. , 2008, Current pharmaceutical design.

[34]  A. Angelini,et al.  A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. , 2007, European heart journal.

[35]  Karen A. Hartman,et al.  Troponin, B‐type natriuretic peptides and outcomes in severe heart failure: Differences between ischemic and dilated cardiomyopathies , 2007, Clinical cardiology.

[36]  M. Boaz,et al.  BNP in septic patients without systolic myocardial dysfunction. , 2006, European journal of internal medicine.

[37]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[38]  M. Fischer,et al.  BNP as a marker of diastolic dysfunction in the general population: Importance of left ventricular hypertrophy , 2005, European journal of heart failure.

[39]  M. Grabowski,et al.  Diagnostic value of BNP in suspected perimyocarditis--a preliminary report. , 2004, Kardiologia polska.

[40]  P. Palatini,et al.  C-reactive protein in acute myocardial infarction: association with heart failure. , 2003, American heart journal.

[41]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[42]  A. Çamsarı,et al.  Increased levels of high sensitive C‐reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation , 2002, European journal of heart failure.

[43]  Romuald Wojnicz,et al.  Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy: Two-Year Follow-Up Results , 2001, Circulation.

[44]  G Thiene,et al.  Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings , 2001, Cardiovascular research.

[45]  P. Poole‐Wilson,et al.  Acute coronary findings at autopsy in heart failure patients with sudden death: results from the assessment of treatment with lisinopril and survival (ATLAS) trial. , 2000, Circulation.

[46]  G. Felker,et al.  Idiopathic cardiomyopathy is less idiopathic than you think: An endomyocardial biopsy study of 1278 patients , 1999 .

[47]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[48]  R. Bonow,et al.  Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.

[49]  B. Strauer,et al.  Cardiac troponin T in patients with clinically suspected myocarditis. , 1997, Journal of the American College of Cardiology.

[50]  B Maisch,et al.  Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.

[51]  B. McManus,et al.  A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.

[52]  K. Nakao,et al.  Increased Plasma Levels of Brain Natriuretic Peptide in Patients With Acute Myocardial Infarction , 1993, Circulation.

[53]  N. Markandu,et al.  Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. , 1993, Journal of human hypertension.

[54]  A. Remppis,et al.  Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. , 1991, The American journal of cardiology.

[55]  A. J. Hauck,et al.  Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. , 1989, Mayo Clinic proceedings.

[56]  B. Cummins,et al.  Cardiac specific troponin-I release in canine experimental myocardial infarction: development of a sensitive enzyme-linked immunoassay. , 1987, Journal of molecular and cellular cardiology.

[57]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016 .

[58]  T. Marwick,et al.  Prediction of Mortality form Global Longitudinal Strain: Comparison with Ejection Fraction and Wall motion scoring , 2009 .

[59]  R. Vasan,et al.  The Framingham Heart Study , 2005 .

[60]  Arthur M. Feldman,et al.  Myocarditis. , 2000, The New England journal of medicine.

[61]  S. Kuribayashi,et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. , 1998, Journal of the American College of Cardiology.

[62]  M. F. Parry,et al.  A Retrospective Analysis , 1990 .

[63]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .